Turner Investments’s NxStage Medical Inc. NXTM Stock Holding History

Turner Investments’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-35,000	Closed	-$606K	–	434
2015 Q1	$606K	Buy	35,000 +10,410	+42%	+$184K	0.11%	210
2014 Q4	$441K	Buy	+24,590	New	+$396K	0.05%	352
2014 Q1	–	Sell	-58,240	Closed	-$582K	–	742
2013 Q4	$582K	Buy	+58,240	New	+$661K	0.01%	490

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

CIP

Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Turner Investments's NXTM Position: Q2 2015 in Review

Turner Investments sold out of NxStage Medical Inc. (NXTM) in Q2 2015, closing a stake of 35,000 shares — an estimated $606K sold.

Turner Investments first reported a position in NXTM in Q4 2013 and held it in 3 quarters. The position peaked at $606K in Q1 2015. 139 funds tracked by Wall St. Rank hold NXTM as of Q2 2015.

Turner Investments reported no remaining NxStage Medical Inc. position as of Q2 2015 after selling out during the quarter.
Turner Investments sold 35,000 NxStage Medical Inc. shares in Q2 2015, an estimated $606K.
Turner Investments first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 3 quarters.
Turner Investments's NxStage Medical Inc. position peaked at $606K in Q1 2015.
139 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.